Releases | Medable
Releases
Medable and ICON Exceed Patient eConsent Adoption Goals for Women’s Health Study on Menopause
3 min
Medable and ICON exceeded eConsent adoption goals in a U.S. menopause study, with more than 85% of participants consenting electronically and 18 sites achieving 100% adoption.
4 min
Medable's groundbreaking study with the Tufts PACT Consortium highlights the transformative impact of decentralized clinical trials (DCTs) on diversity.
4 min
Medable reports 80% revenue growth from portfolio-level eCOA adoption in 2024, reflecting growing confidence in scalable digital solutions for clinical trials.
New Medable AI Capabilities Simplify Digital Clinical Trial Launch with Instant eCOA Generation
3 min
Medable Studio is the first solution to leverage generative AI to reduce eCOA build times to seconds.
3 min
Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital and Decentralized Clinical Trial Platform to Google Cloud Marketplace.
Medable Named Top Patient Engagement Trailblazer by Everest Group
4 min
Clinical research industry’s largest, most diverse global network of patient advocates improves the trial experience across therapeutic areas and technologies.
4 min
Medable Studio for eCOA now available; two top-10 pharma company early adopters.
Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution
3 min
Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.
4 min
Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.
4 min
Medable is partnering with industry leader Masimo to bring best-in-class medical-grade wearable devices to clinical research.
4 min
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.
4 min
Medable announces results from a new research project with Duke University BASE Lab on enhanced electronic informed consent (eIC) in clinical trials.
Medable to Present at 42nd Annual J.P. Morgan Healthcare Conference
1 min
Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.